81 FR 71766 - Importer of Controlled Substances Application: Anderson Brecon, Inc.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 81, Issue 201 (October 18, 2016)
Drug Enforcement Administration
Federal Register Volume 81, Issue 201 (October 18, 2016)
| Page Range | 71766-71766 | |
| FR Document | 2016-25131 |
[Federal Register Volume 81, Number 201 (Tuesday, October 18, 2016)] [Notices] [Page 71766] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-25131] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Application: Anderson Brecon, Inc. ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic class, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before November 17, 2016. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before November 17, 2016. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated her authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (``Deputy Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on June 10, 2016, Anderson Brecon, Inc., DBA PCI of Illinois, 4545 Assembly Drive, Rockford, Illinois 61109 applied to be registered as an importer of oxycodone (9143), a basic class of controlled substance listed in schedule II. The company plans to import the listed controlled substances in bulk over-encapsulated tablets for clinical trial only. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale. Dated: October 11, 2016. Louis J. Milione, Assistant Administrator, Diversion Control Division. [FR Doc. 2016-25131 Filed 10-17-16; 8:45 am] BILLING CODE 4410-09-P
![71766 Federal Register / Vol. 81, No. 201 / Tuesday, October 18, 2016 / Notices
Stryker Corporation (‘‘complainant’’) of DEPARTMENT OF JUSTICE The company plans to import the
Kalamazoo, Michigan. 81 FR 11590 listed controlled substances in bulk
(March 4, 2016). The complaint as Drug Enforcement Administration over-encapsulated tablets for clinical
supplemented alleges violations of trial only. Approval of permit
Section 337 of the Tariff Act of 1930, as [Docket No. DEA–392] applications will occur only when the
amended, 19 U.S.C. 1337, in the sale for registrant’s business activity is
importation, importation, or sale within Importer of Controlled Substances consistent with what is authorized
the United States after importation of Application: Anderson Brecon, Inc. under 21 U.S.C. 952(a)(2). Authorization
certain hospital beds, and components will not extend to the import of FDA
ACTION: Notice of application. approved or non-approved finished
thereof by reason of infringement of
certain claims of U.S. Patent No. dosage forms for commercial sale.
DATES: Registered bulk manufacturers of
7,082,630; U.S. Patent No. 7,690,059 the affected basic class, and applicants Dated: October 11, 2016.
(‘‘the ’059 patent’’); U.S. Patent No. therefore, may file written comments on Louis J. Milione,
7,784,125; and U.S. Patent No. or objections to the issuance of the Assistant Administrator, Diversion Control
8,701,229 (‘‘the ’229 patent’’). The proposed registration in accordance Division.
complaint further alleges that an with 21 CFR 1301.34(a) on or before [FR Doc. 2016–25131 Filed 10–17–16; 8:45 am]
industry in the United States exists as November 17, 2016. Such persons may BILLING CODE 4410–09–P
required by subsection (a)(2) of section also file a written request for a hearing
337. The complaint names Umano on the application pursuant to 21 CFR
Medical Inc. of Quebec, Canada and 1301.43 on or before November 17, DEPARTMENT OF JUSTICE
Umano Medical World Inc. of Quebec, 2016.
Drug Enforcement Administration
Canada as respondents. The Office of ADDRESSES: Written comments should
Unfair Import Investigations is not a be sent to: Drug Enforcement [Docket No. DEA–392]
party in the investigation. Administration, Attention: DEA Federal Importer of Controlled Substances
On September 2, 2016, the parties Register Representative/ODW, 8701 Application: Johnson Matthey Inc.
filed a joint motion to terminate the Morrissette Drive, Springfield, Virginia
investigation based on settlement. The 22152. All requests for hearing must be ACTION: Notice of application.
parties provided confidential and non- sent to: Drug Enforcement
Administration, Attn: Administrator, DATES: Registered bulk manufacturers of
confidential versions of the settlement
8701 Morrissette Drive, Springfield, the affected basic classes, and
agreement and represented that there
Virginia 22152. All requests for hearing applicants therefore, may file written
are no other agreements, written or oral,
should also be sent to: (1) Drug comments on or objections to the
express or implied, between the Settling issuance of the proposed registration in
Enforcement Administration, Attn:
Parties concerning the subject matter of Hearing Clerk/LJ, 8701 Morrissette accordance with 21 CFR 1301.34(a) on
this Investigation. Drive, Springfield, Virginia 22152; and or before November 17, 2016. Such
On September 13, 2016, the ALJ (2) Drug Enforcement Administration, persons may also file a written request
granted the joint motion. Order No. 10. Attn: DEA Federal Register for a hearing on the application
The ALJ found that all of the Representative/ODW, 8701 Morrissette pursuant to 21 CFR 1301.43 on or before
requirements of Commission Rule Drive, Springfield, Virginia 22152. November 17, 2016.
210.21(a)–(b), 19 CFR 210.21(a)–(b), had SUPPLEMENTARY INFORMATION: The ADDRESSES: Written comments should
been met and that there were no public Attorney General has delegated her be sent to: Drug Enforcement
interest concerns that would weigh authority under the Controlled Administration, Attention: DEA Federal
against termination. No petitions for Substances Act to the Administrator of Register Representative/DRW, 8701
review were filed. the Drug Enforcement Administration Morrissette Drive, Springfield, Virginia
(DEA), 28 CFR 0.100(b). Authority to 22152. All requests for hearing must be
The Commission has determined not
exercise all necessary functions with sent to: Drug Enforcement
to review the subject ID.
respect to the promulgation and Administration, Attn: Administrator,
The authority for the Commission’s implementation of 21 CFR part 1301, 8701 Morrissette Drive, Springfield,
determination is contained in section incident to the registration of Virginia 22152. All requests for hearing
337 of the Tariff Act of 1930, as manufacturers, distributors, dispensers should also be sent to: (1) Drug
amended (19 U.S.C. 1337), and in Part importers, and exporters of controlled Enforcement Administration, Attn:
210 of the Commission’s Rules of substances (other than final orders in Hearing Clerk/LJ, 8701 Morrissette
Practice and Procedure (19 CFR part connection with suspension, denial, or Drive, Springfield, Virginia 22152; and
210). revocation of registration) has been (2) Drug Enforcement Administration,
redelegated to the Deputy Assistant Attn: DEA Federal Register
By order of the Commission.
Administrator of the DEA Office of Representative/DRW, 8701 Morrissette
Issued: October 12, 2016. Drive, Springfield, Virginia 22152.
Diversion Control (‘‘Deputy Assistant
Lisa R. Barton, Administrator’’) pursuant to section 7 of Comments and request for hearings on
Secretary to the Commission. 28 CFR part 0, appendix to subpart R. applications to import narcotic raw
[FR Doc. 2016–25094 Filed 10–17–16; 8:45 am] In accordance with 21 CFR material are not appropriate. 72 FR
3417, (January 25, 2007).
Lhorne on DSK30JT082PROD with NOTICES
BILLING CODE 7020–02–P 1301.34(a), this is notice that on June
10, 2016, Anderson Brecon, Inc., DBA SUPPLEMENTARY INFORMATION: The
PCI of Illinois, 4545 Assembly Drive, Attorney General has delegated her
Rockford, Illinois 61109 applied to be authority under the Controlled
registered as an importer of oxycodone Substances Act to the Administrator of
(9143), a basic class of controlled the Drug Enforcement Administration
substance listed in schedule II. (DEA), 28 CFR 0.100(b). Authority to
VerDate Sep<11>2014 13:19 Oct 17, 2016 Jkt 241001 PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 E:\FR\FM\18OCN1.SGM 18OCN1](https://thefederalregister.org/doc/81_FR_71967/page/1.svg)
Document Created: 2016-10-17 23:52:12
Document Modified: 2016-10-17 23:52:12
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic class, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before November 17, 2016. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before November 17, 2016. | |
| FR Citation | 81 FR 71766 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR